Illumina

YTD

ALL

Trade Illumina 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ILMN

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions.

CEO

Jacob Thaysen

CEOJacob Thaysen

Employees

8,600

Employees8,600

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1998

Founded1998

Employees

8,600

Employees8,600

ILMN Key Statistics

Market cap

18.84B

Market cap18.84B

Price-Earnings ratio

22.18

Price-Earnings ratio22.18

Dividend yield

—

Dividend yield—

Average volume

1.60M

Average volume1.60M

High today

$123.34

High today$123.34

Low today

$119.93

Low today$119.93

Open price

$120.35

Open price$120.35

Volume

455.88K

Volume455.88K

52 Week high

$155.53

52 Week high$155.53

52 Week low

$68.70

52 Week low$68.70

Stock Snapshot

As of today, Illumina(ILMN) shares are valued at $123.23. The company's market cap stands at 18.84B, with a P/E ratio of 22.18.

On 2026-03-18, Illumina(ILMN) stock traded between a low of $119.93 and a high of $123.34. Shares are currently priced at $123.23, which is +2.8% above the low and -0.1% below the high.

The Illumina(ILMN)'s current trading volume is 455.88K, compared to an average daily volume of 1.6M.

During the past year, Illumina(ILMN) stock moved between $68.70 at its lowest and $155.53 at its peak.

ILMN News

Nasdaq 1h

Illumina Expands Collaboration With Labcorp To Advance Precision Oncology

(RTTNews) - Illumina, Inc. (ILMN), Wednesday announced an expanded collaboration with Labcorp to advance precision oncology through innovative applications of n...

TipRanks 4h

Labcorp, Illumina expand collaboration to broaden access to oncology testing

Illumina (ILMN) and Labcorp (LH) announced an expanded collaboration to advance precision oncology through applications of next-generation sequencing solutions...

Simply Wall St 1d

How Illumina’s Genomics Insurance Push And Multiomic Alliance Expansion At Illumina Has Changed Its Investment Story

Earlier in March 2026, Illumina announced a collaboration with Veritas Genetics Powered By Fuze Health to integrate whole-genome sequencing into preventive heal...

Analyst ratings

43%

of 23 ratings

Buy

43.5%

Hold

43.5%

Sell

13%

More ILMN News

TipRanks 2d

Illumina announces strategic collaboration with Veritas Genetics

Illumina (ILMN) announced a strategic collaboration with Veritas Genetics Powered By Fuze Health to form a consortium that aims to bring preventive genomics int...

Simply Wall St 3d

Illumina Valuation Check As Genomic Discovery Alliance Expansion Draws Fresh Investor Interest

Illumina (ILMN) is back in focus after the company and Nashville Biosciences expanded the Alliance for Genomic Discovery to 312,000 whole genomes and launched a...

People also own

Based on the portfolios of people who own ILMN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.